It appears to increase the risk of persistent HPV infection, leading to an increased risk of HPV(+) OPSCC, and it is associated with increased TP53 mutations, resulting in HPV(−) HNSCC (Figure 1). Here, TP53 is linked to head and neck squamous cell carcinoma.